Prussian Blue Nanozymes Attenuate Hepatic Fibrogenesis by Disrupting the Oxidative-Inflammatory-Fibrotic Network
{{output}}
Hepatic fibrosis, a progressive pathological condition driven by oxidative stress, chronic inflammation, and hepatic stellate cell (HSC) activation, represents a critical unmet medical need with a current lack of effective therapeutic interventions. Herein, we... ...